PL2497487T3 - Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi - Google Patents

Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Info

Publication number
PL2497487T3
PL2497487T3 PL12170754T PL12170754T PL2497487T3 PL 2497487 T3 PL2497487 T3 PL 2497487T3 PL 12170754 T PL12170754 T PL 12170754T PL 12170754 T PL12170754 T PL 12170754T PL 2497487 T3 PL2497487 T3 PL 2497487T3
Authority
PL
Poland
Prior art keywords
qualitative
changes
treating diabetes
quantitative composition
extracellular dna
Prior art date
Application number
PL12170754T
Other languages
English (en)
Inventor
Dmitry Dmitrievich Genkin
Victor Veniaminovich Tets
Georgy Victorovich Tets
Original Assignee
Cls Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/RU2003/000304 external-priority patent/WO2005007187A1/ru
Application filed by Cls Therapeutics Ltd filed Critical Cls Therapeutics Ltd
Publication of PL2497487T3 publication Critical patent/PL2497487T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12170754T 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi PL2497487T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/RU2003/000304 WO2005007187A1 (en) 2003-07-14 2003-07-14 Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment
RU2004108057/14A RU2269358C2 (ru) 2003-07-14 2004-03-12 Способ лечения генерализованных инфекций, вызываемых бактериями, или заболеваний, вызываемых грибами и простейшими, или атеросклероза, или сахарного диабета, или заболеваний, связанных с реакцией гиперчувствительности замедленного типа, или заболеваний, обусловленных мутациями генов соматических клеток
EP12170754.1A EP2497487B1 (en) 2003-07-14 2004-07-01 Method for treating diabetes and atherosclerosis associated with changes of qualitative and/quantitative composition of blood extracellular DNA
EP04775224A EP1661579B1 (en) 2003-07-14 2004-07-01 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna

Publications (1)

Publication Number Publication Date
PL2497487T3 true PL2497487T3 (pl) 2014-01-31

Family

ID=34067506

Family Applications (4)

Application Number Title Priority Date Filing Date
PL12170754T PL2497487T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL04775224T PL1661579T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Family Applications After (3)

Application Number Title Priority Date Filing Date
PL04775224T PL1661579T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia układowego zakażenia bakteryjnego związanego ze zmianami jakościowymi i/lub ilościowymi kładu pozakomórkowego DNA krwi
PL12170757T PL2497488T3 (pl) 2003-07-14 2004-07-01 Sposób leczenia reakcji nadwrażliwości typu opóźnionego związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
PL12170750T PL2497486T3 (pl) 2003-07-14 2004-07-01 Sposoby leczenia chorób powodowanych przez grzyby i pierwotniaki, związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi

Country Status (6)

Country Link
US (1) US20070104702A1 (pl)
EP (4) EP2497487B1 (pl)
ES (4) ES2388605T3 (pl)
PL (4) PL2497487T3 (pl)
RU (1) RU2269358C2 (pl)
WO (1) WO2005004789A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
WO2006130034A1 (fr) 2005-04-25 2006-12-07 Dmitry Dmitrievich Genkin Procede pour prolonger la duree de vie d'animaux ou de l'humain
US8871200B2 (en) 2006-11-28 2014-10-28 Cls Therapeutics Limited Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
EP2488160B1 (en) * 2009-10-16 2020-07-01 Lifecare Innovations Pvt. Ltd. Liposomal amphotericin formulation comprising cholesterol for treating fungal infections
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
ES2799515T3 (es) * 2015-05-22 2020-12-18 Dmitry Dmitrievich Genkin ADN extracelular como una diana terapéutica en la neurodegeneración
AU2019209770B2 (en) 2018-01-16 2025-07-31 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024530A1 (de) * 1990-08-02 1992-02-06 Klinger & Co Dr Verfahren zur bekaempfung von viren
FR2666096B1 (fr) * 1990-08-21 1993-12-31 Sfri Sa Nouveau procede de dosage d'acide desoxyribonucleique present en position extracellulaire dans un milieu.
US5484589A (en) * 1992-04-20 1996-01-16 Rufeld, Inc. Anti-viral methods using RNAse and DNAse
NZ331063A (en) * 1996-02-05 2000-03-27 Inc Genentech Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition
US6391607B1 (en) * 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
AU2003298972A1 (en) * 2003-07-14 2005-02-04 Dmitry Dmitrievich Genkin Method for treating oncological, virulent and somatic diseases, method for controlling treatment efficiency, pharmaceutical agents and composition for carrying out said treatment

Also Published As

Publication number Publication date
ES2388605T3 (es) 2012-10-16
EP1661579B1 (en) 2012-06-06
RU2269358C2 (ru) 2006-02-10
PL1661579T3 (pl) 2012-11-30
PL2497486T3 (pl) 2014-01-31
ES2433918T3 (es) 2013-12-13
PL2497488T3 (pl) 2014-01-31
WO2005004789A3 (en) 2005-03-24
ES2434112T3 (es) 2013-12-13
EP2497488A1 (en) 2012-09-12
ES2434111T3 (es) 2013-12-13
EP1661579A4 (en) 2009-11-25
EP2497486B1 (en) 2013-08-07
WO2005004789A2 (en) 2005-01-20
EP1661579A2 (en) 2006-05-31
US20070104702A1 (en) 2007-05-10
EP2497488B1 (en) 2013-08-07
EP2497487B1 (en) 2013-08-07
EP2497486A1 (en) 2012-09-12
EP2497487A1 (en) 2012-09-12
RU2004108057A (ru) 2005-09-27

Similar Documents

Publication Publication Date Title
GB2423819B (en) Apparatus and method for analysis of molecules
EP1971437A4 (en) METHOD AND APPARATUS FOR FILTRATION OF BIOLOGICAL SAMPLES
AU2003298245A8 (en) Method for analyzing the luminescence of chemical and/or biological samples
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
IL176259A0 (en) Compositions and methods for treating diabetes
EP1924293A4 (en) COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF DIABETES TYPE I
EP1659405A4 (en) BIOSENSOR AND METHOD OF ANALYTIC MEASUREMENT
DE602004022270D1 (de) Zusammensetzung und verfahren für die flüssig- extraktion von metallen unter verwendung von aldoxim
IL154387A0 (en) Apparatus and method for collectingsoil solution samples
ZA200409331B (en) Method of treating diabetes
PL2497487T3 (pl) Sposoby leczenia cukrzycy i miażdżycy naczyń krwionośnych związanych ze zmianami jakościowymi i/lub ilościowymi składu pozakomórkowego DNA krwi
AU2003249106A8 (en) Method and apparatus for analyzing biological tissues
EP1774029A4 (en) METHOD FOR DETECTING THE RISKS OF NON-INSULIN-DEPENDENT DIABETES AND FOR TREATING THIS TYPE OF DIABETES
IL161073A0 (en) Composition and method for treating diabetes
IL185555A0 (en) Method and composition for treating diabetes
EP1789395B8 (en) Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
EP1959021A4 (en) METHOD FOR DETERMINING CHOLESTEROLEMIA IN LIPOPROTEIN OF THE REMNANT TYPE, REAGENT AND KIT
EP1545554A4 (en) METHOD AND COMPOSITIONS FOR TREATING DIABETES MELLITUS
AU2003247442A8 (en) Apparatus and method for relative or quantitative comparison of multiple samples
EP1789592A4 (en) METHOD FOR IDENTIFYING AND QUANTIFYING SHORT OR SMALL ARN
FI20031678A0 (fi) Näytteen käsittelymenetelmä ja järjestely siihen
EP1787119A4 (en) COMPOSITION FOR ANALYZING SUGAR DIABETES AND / OR RETINAL VASCULAR DISEASE AND METHOD OF ANALYSIS THEREOF
AU2002367706A1 (en) Method and apparatus for analyizing biological tissue specimens
AU2003228787A8 (en) Composition and method for reducing post-prandial blood glucose
EP1910963A4 (en) METHOD, SYSTEM AND COMPUTER PROGRAM FOR IDENTIFYING BINDING CONFORMATIONS OF CHEMICAL FRAGMENTS AND BIOLOGICAL MOLECULES